Surmodics Inc
SRDXDelisted Nov 19, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000924717
Surmodics Inc was delisted on Nov 19, 2025; its insiders filed their last Form 4 on Nov 19, 2025; 146 institutions reported holding it in 13F filings for Q3 2025, worth $345.2M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 146
- Q3 2025, +11 vs. previous quarter
- 13F value
- $345.2M
- Reported value at the end of Q3 2025
- Superinvestors holding
- 0
- At the end of Q3 2025
Superinvestors holding SRDX, Q3 2025
No superinvestor reported holding SRDX at the end of Q3 2025.
Latest insider trades
Open-market purchases and sales by Surmodics Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 (view filing) | Nov 26 | 1 day | Arens Timothy J.Chief Financial Officer | SSale | −7.01K | $39.44 | −$276.4K | −9.1%70.3K after | |
| Nov 30, 2022 (view filing) | Nov 28 | 2 days | Bedoya Jose HDirector | SSale | −4.37K | $34.89 | −$152.3K | −15.3%24.2K after | |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Kalich Ronald B SrDirector | SSale | −2.73K | $33.48 | −$91.5K | −8.3%30.2K after | |
| Nov 15, 2022 (view filing) | Nov 14 | 1 day | Dantzker DavidDirector | SSale | −2.77K | $33.00 | −$91.5K | −7.5%34.2K after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Maharaj Gary RPresident & CEO | SSale | −3.90K | $44.97 | −$175.4K | −2.5%155.1K after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Maharaj Gary RPresident & CEO | SSale | −100 | $45.55 | −$4.55K | −0.1%155.0K after | |
| Mar 2, 2022 (view filing) | Feb 28 | 2 days | Knight Susan EDirector | SSale | −4.37K | $44.97 | −$196.3K | −12.6%30.2K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Stich Joseph J.SVP, HR and GM, IVD | SSale | −2.50K | $50.00 | −$125.0K | −5.2%45.8K after | |
| Dec 1, 2021 (view filing) | Nov 30 | 1 day | Bedoya Jose HDirector | SSale | −5.58K | $44.00 | −$245.3K | −19.6%22.8K after | |
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Dantzker DavidDirector | SSale | −3.48K | $47.01 | −$163.4K | −10.1%30.8K after |
Top 10 13F holders, Q3 2025
The largest institutional positions in Surmodics Inc at the end of Q3 2025; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,148,587 | $34.3M | 0.00% | +1,296+0.1% | Added |
| Alliancebernstein L.P. | 887,193 | $26.5M | 0.01% | +36,722+4.3% | Added |
| Vanguard Group Inc | 809,876 | $24.2M | 0.00% | −3090.0% | Reduced |
| Oddo BHF Asset Management SAS | 610,000 | $18.2M | 0.69% | +341,900+127.5% | Added |
| Hudson Bay Capital Management LP | 536,275 | $16.0M | 0.10% | +136,275+34.1% | Added |
| Qube Research & Technologies Ltd | 418,940 | $12.5M | 0.02% | +24,956+6.3% | Added |
| Gabelli Funds LLC | 384,371 | $11.5M | 0.08% | −30,467−7.3% | Reduced |
| Readystate Asset Management LP | 383,016 | $11.4M | 0.56% | −50,596−11.7% | Reduced |
| Citadel Advisors LLC | 365,110 | $10.9M | 0.01% | +302,757+485.6% | Added |
| Geode Capital Management, LLC | 339,036 | $10.1M | 0.00% | +2,797+0.8% | Added |
Holders of 5% or more of SRDX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Surmodics Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Alliancebernstein L.P. | 13G/A | 5.90%849.4K shares | −1.40 ppfrom 7.30% | Nov 15, 20242 filings | May 14, 2025 | SEC |